Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$394,386
+$329,506 QoQ
Shares Held
241,955
+507.9% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,458,033,396 across 316 Biotechnology names. CDXS ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in CDXS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $394,386 | 241,955 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $64,880 | 39,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $55,497 | 22,745 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $82,101 | 33,648 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $88,522 | 32,908 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,255,549 | 263,218 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $791,008 | 256,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,038,190 | 334,900 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,855,905 | 531,778 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,781,166 | 583,989 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,299,979 | 687,820 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,197,462 | 1,141,951 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,119,047 | 994,939 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,748,064 | 1,018,898 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,226,147 | 697,384 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,871,783 | 561,356 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,812,884 | 427,395 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,670,595 | 661,036 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,984,326 | 300,272 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,106,207 | 357,732 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,282,357 | 361,833 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,482,354 | 113,713 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $503,998 | 42,930 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $977,219 | 85,721 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||